Law360
Sunshine Overseas: Transparency Rules For Life Sciences
November 2012
In the wake of the U.S. Physician Payments Sunshine Act (signed into law in March 2010), European, Asian and Australian governmental bodies and trade associations have been rapidly adopting “Sunshine-like” transparency and disclosure requirements applicable to life sciences companies.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents Archimed in US$1.1 Billion Acquisition of Esperion TherapeuticsMay 1, 2026DOJ Announces FOCUS Initiative to Work with Data Miners Filing Qui TamsApril 30, 2026Sidley Represents Apollo on its Strategic Investment in vVARDISApril 30, 2026Sidley Represents ModMed in Its Acquisition of Bonsai HealthApril 22, 2026Most-Favored-Nation Drug Pricing Policy: Executive Actions, Manufacturer Agreements, and Growing Congressional ScrutinyApril 22, 2026Ninth Circuit Rejects $8.5M Award Of Attorneys’ Fees to FCA WhistleblowerApril 14, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory